Anti-retropulsion Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032

Anti-retropulsion Devices Market by Product Type (Stone Entrapment and Extraction Devices, Stone Retrieval Devices, and Others), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2032 due to the growing prevalence of kidney stones and increasing R&D activiites and product launches in anti-retropulsion devices.

The anti-retropulsion devices market is estimated to grow at a CAGR of 6.69% during the forecast period from 2025 to 2032. The increasing demand for anti-retropulsion devices is primarily driven by the rising prevalence of kidney stones which are often linked to factors like dehydration. Additionally, the growing burden of risk factors such as benign prostatic hyperplasia (BPH), obesity, and sedentary lifestyles, both of which are significant risk factors for the development of kidney stones, further contribute to the market's growth. Technological advancements in anti-retropulsion devices, along with ongoing research and development efforts by key players, are also playing a pivotal role in propelling the positive growth of the anti-retropulsion devices market during the forecast period from 2025 to 2032.

Anti-retropulsion Devices Market Dynamics:

The growing prevalence of kidney stones (urolithiasis) is a key factor driving the expansion of the anti-retropulsion devices market. According to Kidney Research UK data from October 2023, kidney stones affect approximately one in ten individuals in the United Kingdom.

According to data from the Canadian Urological Association in 2023, approximately one in ten people develop a kidney stone at some point in their life in Canada. This condition is more prevalent in men than in women, with active cases on the rise in various regions. This increasing incidence of kidney stones is driving the growth of the market for related medical devices and treatments. Anti-retropulsion devices play a critical role in the management of kidney stones, particularly during procedures like ureteroscopy and lithotripsy. These devices are specifically designed to prevent the migration of stone fragments back into the kidney during treatment. With the growing number of kidney stone cases worldwide, the demand for advanced medical solutions, including anti-retropulsion devices, is expected to continue rising, further contributing to the market's expansion.

The growing incidence of obesity and sedentary lifestyles-key risk factors for kidney stones-further drives market growth. According to the World Health Organization (WHO) in February 2024, over 1 billion people worldwide were affected by obesity in 2022, including 650 million adults, 340 million adolescents, and 39 million children. This number is expected to rise, creating a greater demand for kidney stone treatments, thereby driving the market growth.

However, challenges such as the risk of device-related complications, lack of skilled professionals, and limited access to anti-retropulsion devices in low-income countries may act as barriers to market growth.

Anti-retropulsion Devices Market Segment Analysis:

Anti-retropulsion Devices Market by Product Type (Stone Entrapment and Extraction Devices, Stone Retrieval Devices, and Others), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product type segment of the anti-retropulsion devices, stone entrapment and extraction devices are expected to capture the largest market share during the forecast period. The is attributed to various advantages associated with these devices. Stone entrapment and extraction devices are highly effective tools for removing kidney stones from the urinary tract, while also minimizing the risk of stone migration.

These devices offer minimally invasive solutions, meaning smaller incisions or no incisions at all, which results in less pain, a lower risk of infection, and quicker recovery times compared to traditional open surgery. For larger stones or those located in difficult-to-reach areas, stone extraction through entrapment proves to be particularly beneficial. These devices are designed to fragment stones into smaller pieces, making them easier to remove or pass naturally, reducing the need for more invasive procedures. This approach not only improves patient comfort but also contributes to more efficient treatment outcomes, promoting faster recovery and preserving overall kidney function.

Stone entrapment and extraction devices also play a crucial role in preventing the proximal migration of stones and fragments during ureteroscopy. This is essential for maintaining visibility and access to the stone, ensuring that the procedure is efficient and reduces the risk of complications associated with stone migration back into the kidney. For instance, devices like the EscapeTM Nitinol Stone Retrieval Device by Boston Scientific are specifically designed to facilitate smoother procedures by minimizing retropulsion, a common issue that can lead to longer operative times and increased procedure complexity.

In addition, the innovative technologies within the stone entrapment and extraction devices category, combined with their growing applications in urological procedures, are expected to significantly drive market growth. As the demand for more effective treatment solutions increases, the anti-retropulsion devices market is set to expand further throughout the forecast period.

North America is expected to dominate the overall anti-retropulsion devices market:

North America is projected to dominate the anti-retropulsion devices market during the forecast period from 2025 to 2032. This growth can be attributed to several critical drivers, including the increasing incidence of kidney stones and urinary cancers, as well as a rise in risk factors associated with kidney stone formation. Furthermore, advancements in technology related to the development of anti-retropulsion devices, coupled with a strong healthcare infrastructure, are expected to significantly propel market expansion in the region.

According to data from the American Kidney Fund (2024), over 1 in 10 men and approximately 1 in 14 women in the United States experienced kidney stones at least once in their lifetime. Additionally, data from the National Institutes of Health (NIH) in 2023 highlighted that kidney stone affects 1 in 11 people, with an estimated 600,000 new cases reported in the United States annually. The rising prevalence of kidney stones is significantly driving the growth of the anti-retropulsion devices market in the region.

The increasing incidence of upper tract urothelial carcinoma (UTUC) and kidney diseases is also a significant driver for the growing demand for anti-retropulsion devices. Patients with urinary cancers and other urinary tract conditions face an elevated risk of developing renal stones, exacerbating the need for effective anti-retropulsion interventions. According to data from the Center for Disease Control and Prevention (CDC) published in June 2024, approximately 35 million cases of chronic kidney disease (CKD) were reported in the United States in 2023. CKD impairs kidney function, leading to the formation and accumulation of renal stones, thereby fueling demand for anti-retropulsion devices and promoting market expansion.

Anti-retropulsion Devices Market Key Players:

Some of the key market players operating in the anti-retropulsion devices market include Boston Scientific Corporation, Cook, Rocamed, Accordion Medical, EndoTheia, Inc., KARL STORZ, Olympus Corporation, Coloplast Group, Endotherapeutics Pty Ltd., ELMED Medical Systems, PENTAX Medical, UROMED Kurt Drews KG, BD, Dornier MedTech, NeoScope Inc., OTU Medical, Clarion Medical Technologies, Calyxo, Inc., EMS Urology, Happiness Works Medical, and others.

Recent Developmental Activities in the Anti-retropulsion Devices Market:

• In November 2024, EndoTheia, Inc., a frontrunner in innovative surgical technology, announced the successful completion of the first-in-human clinical trial for its FlexStone(TM) Basket. The cutting-edge device provides unmatched flexibility and control, allowing for the retrieval of stones from difficult-to-reach and challenging locations, thereby enhancing the precision and effectiveness of stone removal procedures. The success of this trial marked a significant milestone in advancing minimally invasive treatments for kidney stones.

Key Takeaways from the Anti-retropulsion Devices Market Report Study

• Market size analysis for current Anti-retropulsion Devices Market size (2024), and market forecast for 8 years (2025 to 2032)
• Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.
• Key companies dominating the Anti-retropulsion Devices market.
• Various opportunities are available for the other competitors in the Anti-retropulsion Devices Market space.
• What are the top-performing segments in 2024? How these segments will perform in 2032?
• Which are the top-performing regions and countries in the current Anti-retropulsion Devices market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for Anti-retropulsion Devices market growth in the coming future?

Target Audience who can be benefited from this Anti-retropulsion Devices Market Report Study

• Anti-retropulsion Devices product providers
• Research organizations and consulting companies
• Anti-retropulsion Devices related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and Traders dealing in Anti-retropulsion Devices
• Various end-users who want to know more about the Anti-retropulsion Devices Market and the latest technological developments in the Anti-retropulsion Devices Market.

Frequently Asked Questions for the Anti-retropulsion Devices Market:

1. What are Anti-retropulsion Devices?

• Anti-retropulsion devices for kidney stones are medical instruments designed to prevent the backward movement (retropulsion) of kidney stones during minimally invasive procedures, such as ureteroscopy or lithotripsy. When a stone is being fragmented or removed, there is a risk that it could move away from the targeted area, potentially causing complications or making the procedure less effective.

2. What is the market for ureteroscopes?

• The anti-retropulsion devices market is estimated to grow at a CAGR of 6.69% during the forecast period from 2025 to 2032.

3. What are the drivers for the Anti-retropulsion Devices market?

• The increasing demand for anti-retropulsion devices is primarily driven by the rising prevalence of kidney stones which are often linked to factors like dehydration. Additionally, the growing burden of risk factors such as benign prostatic hyperplasia (BPH), obesity, and sedentary lifestyles, both of which are significant risk factors for the development of kidney stones, further contribute to the market's growth. Technological advancements in anti-retropulsion devices, along with ongoing research and development efforts by key players, are also playing a pivotal role in propelling the positive growth of the anti-retropulsion devices market during the forecast period from 2025 to 2032.

4. Who are the key players operating in the Anti-retropulsion Devices market?

• Some of the key market players operating in the anti-retropulsion devices market include Boston Scientific Corporation, Cook, Rocamed, Accordion Medical, EndoTheia, Inc., KARL STORZ, Olympus Corporation, Coloplast Group, Endotherapeutics Pty Ltd., ELMED Medical Systems, PENTAX Medical, UROMED Kurt Drews KG, BD, Dornier MedTech, NeoScope Inc., OTU Medical, Clarion Medical Technologies, Calyxo, Inc., EMS Urology, Happiness Works Medical, and others.

5. Which region has the highest share in the Anti-retropulsion Devices market?

• North America is projected to dominate the ureteroscope market during the forecast period from 2025 to 2032. This growth can be attributed to several critical drivers, including the increasing incidence of kidney stones and urinary cancers, as well as a rise in risk factors associated with kidney stone formation. Furthermore, advancements in technology related to the development of anti-retropulsion devices, coupled with a strong healthcare infrastructure, are expected to significantly propel market expansion in the region.